ABUS
Arbutus BiopharmaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ABUS vs peer average
50/100
ABUS vs. peer average (C vs. C)
Grade spread
A 1 · B 1 · C 4 · D 3
Graded peers loaded
Coverage
9 graded
90% of tracked
Peer overview
TBPH is the first available peer comparator.
Similar mid-cap biopharma with clinical-stage programs and comparable market cap; useful comparator for financing/valuation dynamics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ABUS
Arbutus Biopharma
TBPH
Theravance Biopharma
Grade
C
D
Momentum
49
31
Value
41
57
Sentiment
65
47
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs TBPH
ABUS / TBPH
Grade Position
In line
ABUS vs. peer average (C vs. C)
50/100
Momentum
49
ABUSValue
41
TBPHSentiment
65
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ABUS
TBPH is the first peer returned for this comparison set.